AU2001290588A1 - Inhibitors of prenyl-protein transferase - Google Patents

Inhibitors of prenyl-protein transferase

Info

Publication number
AU2001290588A1
AU2001290588A1 AU2001290588A AU9058801A AU2001290588A1 AU 2001290588 A1 AU2001290588 A1 AU 2001290588A1 AU 2001290588 A AU2001290588 A AU 2001290588A AU 9058801 A AU9058801 A AU 9058801A AU 2001290588 A1 AU2001290588 A1 AU 2001290588A1
Authority
AU
Australia
Prior art keywords
prenyl
inhibitors
protein transferase
transferase
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290588A
Inventor
S. Jane Desolms
Anthony W. Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2001290588A1 publication Critical patent/AU2001290588A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
AU2001290588A 2000-09-05 2001-08-30 Inhibitors of prenyl-protein transferase Abandoned AU2001290588A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23010500P 2000-09-05 2000-09-05
US60230105 2000-09-05
PCT/US2001/027013 WO2002020015A1 (en) 2000-09-05 2001-08-30 Inhibitors of prenyl-protein transferase

Publications (1)

Publication Number Publication Date
AU2001290588A1 true AU2001290588A1 (en) 2002-03-22

Family

ID=22863969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290588A Abandoned AU2001290588A1 (en) 2000-09-05 2001-08-30 Inhibitors of prenyl-protein transferase

Country Status (2)

Country Link
AU (1) AU2001290588A1 (en)
WO (1) WO2002020015A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7507760B2 (en) * 2004-01-22 2009-03-24 Neuromed Pharmaceuticals Ltd. N-type calcium channel blockers
DE602005021878D1 (en) 2004-05-03 2010-07-29 Janssen Pharmaceutica Nv DIASTERE ELECTIVE SYNTHESIS PROCESS WITH 6-BROMO-4- (3-CHLOROPHENYL) -2-METHOXYCHINOLINE
ATE398612T1 (en) * 2004-05-03 2008-07-15 Janssen Pharmaceutica Nv DIASTEREOSELECTIVE ADDITION OF LITHIATED N-METHYLIMIDAZOLE TO SULFINIMINE
US7888376B2 (en) * 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2478500A (en) * 1998-12-08 2000-06-26 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Also Published As

Publication number Publication date
WO2002020015A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
EP1324985A4 (en) Inhibitors of prenyl-protein transferase
EP1087770A4 (en) Inhibitors of prenyl-protein transferase
EP1165082A4 (en) Inhibitors of prenyl-protein transferase
AU2001241927A1 (en) Inhibitors of p38-alpha kinase
AU2002213485A1 (en) Inhibitors of protein kinases
AU2001237041A1 (en) Kinase inhibitors
EP1165084A4 (en) Inhibitors of prenyl-protein transferases
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
EP1091736A4 (en) Inhibitors of prenyl-protein transferase
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
AU7354900A (en) Inhibitors of prenyl-protein transferase
AU2477400A (en) Inhibitors of prenyl-protein transferase
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2001238424A1 (en) Inhibitors of prenyl-protein transferase
AU2274101A (en) Inhibitors of prenyl-protein transferase
EP1158982A4 (en) Inhibitors of prenyl-protein transferase
AU2002237657A1 (en) Indole-type inhibitors of p38 kinase
AU2001230864A1 (en) Inhibitors of prenyl-protein transferase
AU2001229320A1 (en) Inhibitors of prenyl-protein transferase
AU2001227756A1 (en) Inhibitors of prenyl-protein transferase
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2002254375A1 (en) Inhibitors of prenyl-protein transferase
AU2001251445A1 (en) Inhibitors of prenyl-protein transferase
AU2478500A (en) Inhibitors of prenyl-protein transferase